The researchers developed SyntheMol, an AI model generating structures and chemical recipes for novel drugs targeting antibiotic-resistant strains. This innovative approach aims to address the urgent need for new antibiotics.
Using AI, SyntheMol can design molecules that have never been seen before in nature, opening up opportunities for exploring untapped chemical compounds with potential antibacterial properties.
The traditional approach of screening existing drugs for antibiotic development is limited by the vastness of chemical space. SyntheMol's generative AI offers a more comprehensive and innovative way to discover potential antibacterial compounds.
The AI model, SyntheMol, aims to revolutionize drug development by exploring uncharted chemical spaces with the potential to discover more effective antibiotics to combat bacterial resistance.
[
add
]
[
|
|
...
]